The molecular diagnostic laboratory provides quantitative polymerase chain reaction (PCR), mutation analysis and gene sequencing to support therapy selection, treatment monitoring and minimal residual disease detection with a complete range of clinically actionable tests; Provided as part of MPLN's evidence based comprehensive strategic reflex testing protocol or can be ordered individually. Molecular Diagnostics Flyer (DEC2018)

Molecular Diagnostics Tests

A-Z Molecular Diagnostic Oncology Tests

ABL Kinase Gene Mutation Analysis; Gleevec® Resistance*

AML Mutation Analysis Panel

B-cell IGH Gene Rearrangement by Next Generation Sequencing

BCR/ABL qRT PCR, Major p210 and Minor p190 Mutations, Minimal Residual Disease

BCR/ABL1 t(9;22) by FISH

BRAF Mutation Analysis by Next Generation Sequencing

CALR Type 1 / Type 2 Mutation Analysis by Next Generation Sequencing

CEBPA Mutation Analysis*

Chlamydia Trachomatis (CT), Qualitative by Aptima COMBO® 2 TMA

Colon Cancer Panel by Next Generation Sequencing

EGFR Mutation Analysis by Next Generation Sequencing

FLT3 Mutation Analysis*

GIST Panel - KIT, PDGFRA by Next Generation Sequencing

Herpes Simplex Virus (HSV) Type 1 and 2 Qualitative by PCR

Human Papillomavirus (HPV) Genotyping

Human Papillomavirus (HPV) High Risk by Aptima HPV

IDH1/IDH2 Mutation Analysis by Next Generation Sequencing

IgVH Somatic Hypermutation by Next Generation Sequencing

JAK2 Exon12 Mutation Analysis by Next Generation Sequencing

← prev 1 2 next →